T1DM

N = 77

T2DM

Total

N = 381

Diet and exercise

N = 2

OGLD treatment

N = 187

Insulin treatment

N = 27

OGLD + Insulin treatment

N = 88

Total

N = 304

People tested for HbA1c

58 (80.56)

2 (100.00)

118 (68.60)

20 (80.00)

64 (76.19)

204 (72.08)

262 (73.80)

Frequency of tests for HbA1c during past year

1.59 (1.19)

2.00 (0.00)

1.30 (0.69)

1.26 (0.73)

1.32 (0.68)

1.31 (0.69)

1.37 (0.83)

Value of last HbA1c measurement (%)

9.17 (2.19)

6.20 (0.28)

7.81 (2.35)

9.19 (2.45)

9.45 (2.55)

8.44 (2.53)

8.60 (2.48)

No. of people achieving HbA1c < 7%

6 (10.71)

2 (100.00)

48 (41.03)

4 (21.05)

12 (18.75)

66 (32.67)

72 (27.91)

Last FBG measurement (mg/dl)

145.06 (69.29)

92.65 (31.75)

136.07 (59.77)

149.94 (71.38)

145.96 (73.13)

139.82 (64.84)

140.85 (65.67)

FBG ≤ 100 mg/dL

19 (27.14)

1 (50.00)

52 (29.21)

8 (32.00)

23 (27.71)

84 (29.17)

103 (28.77)

Last PPBG measurement (mg/dl)

173.70 (79.40)

81.00 (0.00)

186.70 (85.41)

206.63 (100.25)

192.65 (111.21)

189.76 (94.86)

185.97 (91.51)

No. of people achieving global target*

3 (4.69)

0 (0.00)

6 (3.45)

0 (0.00)

1 (1.18)

7 (2.45)

10 (2.86)

People with diabetes-related complications

44 (59.46)

1 (50.00)

117 (64.29)

19 (73.08)

72 (81.82)

209 (70.13)

253 (68.01)

People with microvascular complications

43 (58.11)

1 (50.00)

112 (61.54)

18 (69.23)

71 (80.68)

202 (67.79)

245 (65.86)

People with macrovascular complications

2 (2.70)

0 (0.00)

21 (11.54)

5 (19.23)

14 (15.91)

40 (13.42)

42 (11.29)

Hypoglycemia in the preceding three months

36 (49.32)

0 (0.00)

24 (13.11)

13 (48.15)

24 (27.27)

61 (20.33)

97 (26.01)

Severe hypoglycemiain the past 12 months

15 (21.43)

0 (0.00)

6 (3.26)

4 (14.81)

7 (8.24)

17 (5.70)

32 (8.70)

Hospitalisations due to diabetes in the past 12 months

32 (42.67)

0 (0.00)

22 (12.22)

10 (40.00)

26 (29.89)

58 (19.73)

90 (24.39)